There are 807 resources available
Invited Discussant 181MO, 182MO and 183MO
Presenter: Smruti Koppikar
Session: Mini Oral session: Gynaecological tumours
Resources:
Slides
Webcast
Q&A and discussion
Presenter: Michelle Poon
Session: Developing immunotherapies in haematolgical malignancies
Resources:
Slides
Webcast
Q&A and discussion
Presenter: Naomi Kiyota
Session: Potential benefits and limitations of IO in localised head and neck cancer
Resources:
Slides
Webcast
Q&A and discussion
Presenter: Inge-Marie Svane
Session: Cancer immunotherapy in 2022
Resources:
Slides
Webcast
Q&A and discussion
Presenter: Paolo G. Casali
Session: Latest advances in the treatment of gastrointestinal stromal tumour (GIST)
Resources:
Slides
Webcast
45MO - Sotorasib in combination with panitumumab in refractory KRAS G12C-mutated colorectal cancer: Safety and efficacy for phase Ib full expansion cohort
Presenter: Yasutoshi Kuboki
Session: Proffered Paper and Mini Oral session: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
46MO - FRESCO-2: A global / multiregional phase III clinical trial (MRCT) evaluating the efficacy and safety of fruquintinib in patients with metastatic colorectal cancer
Presenter: Takayuki Yoshino
Session: Proffered Paper and Mini Oral session: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant 45MO and 46MO
Presenter: Jeanne Tie
Session: Proffered Paper and Mini Oral session: Gastrointestinal tumours
Resources:
Slides
Webcast
184MO - Efficacy and safety of sintilimab plus paclitaxel and cisplatin as neoadjuvant therapy for locally advanced cervical cancer: A phase II trial
Presenter: Jihong Liu
Session: Mini Oral session: Gynaecological tumours
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Presenter: Jeanne Tie
Session: Proffered Paper and Mini Oral session: Gastrointestinal tumours
Resources:
Slides
Webcast